313 related articles for article (PubMed ID: 20119648)
1. Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease.
Oka H; Toyoda C; Yogo M; Mochio S
J Neurol; 2010 Jun; 257(6):969-76. PubMed ID: 20119648
[TBL] [Abstract][Full Text] [Related]
2. Olfactory function combined with morphology distinguishes Parkinson's disease.
Sengoku R; Matsushima S; Bono K; Sakuta K; Yamazaki M; Miyagawa S; Komatsu T; Mitsumura H; Kono Y; Kamiyama T; Ito K; Mochio S; Iguchi Y
Parkinsonism Relat Disord; 2015 Jul; 21(7):771-7. PubMed ID: 25986741
[TBL] [Abstract][Full Text] [Related]
3. Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease.
Mizutani Y; Nakamura T; Okada A; Suzuki J; Watanabe H; Hirayama M; Sobue G
Parkinsonism Relat Disord; 2014 May; 20(5):520-4. PubMed ID: 24637128
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular dysautonomia in de novo Parkinson's disease without orthostatic hypotension.
Oka H; Toyoda C; Yogo M; Mochio S
Eur J Neurol; 2011 Feb; 18(2):286-292. PubMed ID: 20602633
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of orthostatic hypotension in Parkinson's disease.
Oka H; Yoshioka M; Onouchi K; Morita M; Mochio S; Suzuki M; Hirai T; Ito Y; Inoue K
Brain; 2007 Sep; 130(Pt 9):2425-32. PubMed ID: 17673498
[TBL] [Abstract][Full Text] [Related]
6. Relationship and factor structure in multisystem neurodegeneration in Parkinson's disease.
Hattori T; Orimo S; Hallett M; Wu T; Inaba A; Azuma R; Mizusawa H
Acta Neurol Scand; 2014 Dec; 130(6):347-53. PubMed ID: 25209841
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease.
Iijima M; Osawa M; Momose M; Kobayakawa T; Saito S; Iwata M; Uchiyama S
Mov Disord; 2010 Jul; 25(9):1143-9. PubMed ID: 20131383
[TBL] [Abstract][Full Text] [Related]
8. Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms.
Rocchi C; Pierantozzi M; Galati S; Chiaravalloti A; Pisani V; Prosperetti C; Lauretti B; Stampanoni Bassi M; Olivola E; Schillaci O; Stefani A
CNS Neurosci Ther; 2015 Sep; 21(9):727-32. PubMed ID: 26205884
[TBL] [Abstract][Full Text] [Related]
9. Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease.
Suzuki M; Nakamura T; Hirayama M; Ueda M; Katsuno M; Sobue G
J Neurol; 2017 Feb; 264(2):333-340. PubMed ID: 27900499
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessment.
Strano S; Fanciulli A; Rizzo M; Marinelli P; Palange P; Tiple D; De Vincentis G; Calcagnini G; Censi F; Meco G; Colosimo C
J Neurol Sci; 2016 Nov; 370():251-255. PubMed ID: 27772769
[TBL] [Abstract][Full Text] [Related]
11. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
[TBL] [Abstract][Full Text] [Related]
12. Olfactory dysfunction and parasympathetic dysautonomia in Parkinson's disease.
Kang P; Kloke J; Jain S
Clin Auton Res; 2012 Aug; 22(4):161-6. PubMed ID: 22314778
[TBL] [Abstract][Full Text] [Related]
13. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease.
Oka H; Toyoda C; Yogo M; Mochio S
J Neural Transm (Vienna); 2011 Sep; 118(9):1323-7. PubMed ID: 21331459
[TBL] [Abstract][Full Text] [Related]
14. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
[TBL] [Abstract][Full Text] [Related]
15. Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?
Kim JS; Park HE; Park IS; Oh YS; Ryu DW; Song IU; Jung YA; Yoo IR; Choi HS; Lee PH; Lee KS
Eur J Neurol; 2017 Feb; 24(2):349-356. PubMed ID: 27888574
[TBL] [Abstract][Full Text] [Related]
16. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
Izawa MO; Miwa H; Kajimoto Y; Kondo T
Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson's disease and de novo dementia with Lewy bodies.
Oka H; Umehara T; Nakahara A; Matsuno H
BMC Neurol; 2020 Sep; 20(1):350. PubMed ID: 32948137
[TBL] [Abstract][Full Text] [Related]
18. Body weight and dysautonomia in early Parkinson's disease.
Umehara T; Nakahara A; Matsuno H; Toyoda C; Oka H
Acta Neurol Scand; 2017 May; 135(5):560-567. PubMed ID: 27357472
[TBL] [Abstract][Full Text] [Related]
19. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.
Lee PH; Yeo SH; Kim HJ; Youm HY
Mov Disord; 2006 Nov; 21(11):1975-7. PubMed ID: 16960860
[TBL] [Abstract][Full Text] [Related]
20. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
Kikuchi A; Baba T; Hasegawa T; Sugeno N; Konno M; Takeda A
Parkinsonism Relat Disord; 2011 Nov; 17(9):698-700. PubMed ID: 21840242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
